¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Drug development and industrial pharmacy."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • hematological drug
    Ç÷¾×ÀÛ¿ë¾à
  • inotropic drug
    ¼öÃàÃËÁø¾à
  • mucosal protective drug
    Á¡¸·º¸È£Á¦
  • narcotic drug
    ¸¶¾à
  • nonsteroidal antiinflammatory drug
    ºñ½ºÅ×·ÎÀ̵å¼Ò¿°Á¦, ºñ½ºÅ×·ÎÀ̵åÇ׿°ÁõÁ¦
  • orphan drug
    Èñ±ÍÀǾàǰ
  • parasympathetic drug
    ºÎ±³°¨½Å°æ¾à
  • parasympathomimetic drug
    ºÎ±³°¨ÈïºÐÁ¦
  • prokinetic drug
    À§Àå¿îµ¿ÃËÁøÁ¦
  • psychedelic drug
    ȯ°¢Á¦
  • psychoactive drug
    Á¤½ÅÀÛ¿ë¾à
  • sulfa drug
    ¼úÆÄÁ¦
  • sympathomimetic drug
    ±³°¨½Å°æÈïºÐÁ¦
  • synthetic drug
    ÇÕ¼º¾à
  • topical drug
    ±¹¼Ò¾à
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • maternal and child health
    ¸ðÀÚº¸°Ç(ËÎËö ËÓ˧).
  • maternity and infant hygiene
    ¸ð¼º¿µ¾ÆÀ§»ý (ÇÐ)(ËÎËÛ ËâËôË×̰).
  • maximum and minimum thermometer
    ÃÖ°í ÃÖÀú¿Âµµ°è(õÌÍÔõÌî¸è®öôͪ).
  • maximum and minimum thermometer
    ÃÖ°í ÃÖÀú¿Âµµ°è(Ì§Ë­Ì§ËøËí̬˭).
  • medial and inferior surface
    ¾ÈÂÊ¸é ¹× ¾Æ·¡¸é
  • mesenteries and peritoneal folds
    âÀÚ°£¸· ¹× º¹¸·ÁÖ¸§
  • mitral stenosis and insufficiency
    ½Â¸ðÆÇÇùÂø ¹× Æó¼âºÎÀüÁõ(¡­øÍáðÝÕîïñø).
  • mitral stenosis and insufficiency
    ½Â¸ðÆÇÇùÂø ¹× Æó¼âºÎÀüÁõ(¡­øÍáðÝÕîïñø)
  • mixed anxiety and depression
    È¥À缺 ºÒ¾È¿ì¿ïº´(ûèî¤àõ ÝÕäÌéØê¦Ü»)
  • mixed small and large cell lymphoma
    È¥ÇÕ¼º ´ë¼Ò¼¼Æ÷ ¸²ÇÁÁ¾(¡­ ÓÞá³á¬øà ¡­ðþ)
  • mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
  • mouth and hand synkinesis
    ±¸¼ö°øµ¿¿îµ¿(Ï¢â¢ÍìÔÒê¡ÔÑ).
  • muscle of upper lip and ala of nose, levator =mus
    »ó¼øºñÀͰűÙ
  • muscles of palate and fauces
    ÀÔõÀå ¹× ¸ñ±¸¸Û±ÙÀ°
  • myoclonic epilepsy and raggedred fibers
    °£´ë±ÙÀ°°æ·Ã¼º°£Áú(ÊàÓÛÐÉë¿ÌâÕýàõÊÖòð)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
IMS incurred in military service; Indian Medical Service; industrial methylated spirit; information mana...
indust industrial
IRU industrial rehabilitation unit; interferon reference unit
JIS Japanese industrial standard; juvenile idiopathic scoliosis
MIH Master of Industrial Health; migraine with interval headache; minimal intermittent heparin [dose]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
FDA Federal Drug Administration
FDE Fixed Drug Eruption
HDRA Histoculture Drug Response Assay
IVDU IV drug users
IDU Injecting drug use
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • drug-induced allergic hepatopathy
    ¾à¹° ¾Ë·¹¸£±â¼º °£º´Áõ, ¾à¹° À¯¹ß ¾Ë·¹¸£±â¼º °£º´Áõ
  • drug-induced autoantibody
    ¾à¹° À¯Àμº ÀÚ°¡ Ç×ü
  • drug-induced cholestais
    ¾àÁ¦¼º ´ãÁó ¿ïü
  • drug-induced enanthema
    ¾à¹° À¯µµ¼º Á¡¸·Áø
  • drug-induced hemolytic anemia
    ¾à¹°¼º ¿ëÇ÷¼º ºóÇ÷, ¾àÁ¦ À¯¹ß¼º ¿ëÇ÷¼º ºóÇ÷
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • drug-induced leukopenia
    ¾à¹°¼º ¹éÇ÷±¸ °¨¼ÒÁõ
  • drug-induced lupus
    ¾à¹° À¯¹ß ·çǪ½º
  • drug-induced psychosis
    ¾à¹° À¯¹ß Á¤½ÅÁõ
  • drug-induced rhinitis
    ¾à¹° ºñ¿°, ¾à¹°¼º ºñ¿°
    µ¿ÀǾî=rhinitis medicamentosa.
  • drug-induced thrombocytopenic purpura
    ¾à¹°¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹ÝÁõ
  • fixed drug enanthema
    °íÁ¤ ¾à¹°¼º Á¡¸·Áø
  • habit forming drug
    ½À°ü¼º ¾àǰ
    À°Ã¼Àû ¶Ç´Â Á¤½ÅÀûÀ¸·Î ÀÇÁ¸¼ºÀ» °®°Ô ÇÏ´Â ¾à¹°.
  • hydantoinlike drug
    È÷´ÜÅäÀÎ¾ç ¾àÁ¦
  • hydrophilic drug
    Ä£¼ö¼º ¾àÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
orphan drug A pharmaceutical that has been abandoned or neglected during its development because it is seen as having only a limited potential for profit. Often a drug which only has a limited target population or which treats a rare disease, thus limiting its financial potential.
(09 Oct 1997)
orphan drug act Law giving incentives to companies developing a drug for a rare disease. The act gives the developer of the first drug of any one type a 7-year exclusive right to market the new drug.
(14 Nov 1997)
orphan drug production Production of drugs or biologicals which are unlikely to be manufactured by private industry unless special incentives are provided by others.
(12 Dec 1998)
targeted drug delivery Delivering a drug to a specific site in the body where it has the greatest effect, instead of allowing it to diffuse to various sites, where it may cause damage or trigger side effects.
(14 Nov 1997)
fixed drug eruption A type of drug eruption that recurs at a fixed site (or sites) following the administration of a particular drug; the lesions usually consist of intensely erythematous and purplish, sharply demarcated macules, and occasionally of herpetic vesicles; the affected areas undergo gradual involution, but flare and enlarge on readministration of the offending drug and may become hyperpigmented.
Iodine eruption, an acneform or follicular eruption or granulomatous lesion caused by a reaction to systemic iodine or iodide administration.
Kaposi's varicelliform eruption, a now rare complication of vaccinia superimposed on atopic dermatitis, with generalised vesicles and vesicopapules and high fever.
Synonym: eczema vaccinatum.
(05 Mar 2000)
food-drug interactions The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet.
(12 Dec 1998)
legislation, drug Laws concerned with manufacturing, dispensing, and marketing of drugs.
(12 Dec 1998)
abstracting and indexing Shortening or summarizing of documents; assigning of descriptors for referencing documents.
(12 Dec 1998)
academies and institutes Organizations representing specialised fields which are accepted as authoritative; may be non-governmental, university or an independent research organization, e.g., national academy of sciences, brookings institution, etc.
(12 Dec 1998)
accounts payable and receivable Short-term debt obligations and assets occurring in the regular course of operational transactions.
(12 Dec 1998)
aged, 80 and over A person 80 years of age and older.
(12 Dec 1998)
algae and fungi Algae represent a group of spore-propagating plants, unicellular or undifferentiated into root, stem, and leaf. They include seaweed and many unicellular fresh water plants, most of which contain chlorophyll. They account for about 90% of the earth's photosynthetic activity. Fungi are eukaryotic, heterotrophic organisms that live as saprobes or parasites and include mushrooms, yeasts, smuts, molds, etc. They lack chlorophyll.
(12 Dec 1998)
alkyl and aryl transferases <enzyme> A somewhat heterogeneous class of enzymes that catalyze the transfer of alkyl or related groups (excluding methyl groups).
Registry number: EC 2.5
(12 Dec 1998)
allergy and immunology A medical specialty concerned with the hypersensitivity of the individual to foreign substances and protection from the resultant infection or disorder.
(12 Dec 1998)
alligators and crocodiles Large, long-tailed reptiles, including caimans, of the order loricata.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • lares and penates
    Áý¾ÈÀÇ ¼öÈ£½Å;ÅÍÁÖ;°¡º¸;°¡Àç
  • make-and-break
    °³Æó½ÄÀÇ
  • mild and bitter
    ´Ü¸À ¾´¸ÀÀÌ ¹Ý¹ÝÀÎ ¸ÆÁÖ
  • milk and water
    ±èºüÁø;¸ß¾ø´Â;¸÷½Ã °¨»óÀûÀÎ
  • mix and match
    ±ÕÇüÀÌ ¸ÂÁö ¾Ê´Â °Í ³¢¸®ÀÇ Â¦Áö¿ò
  • nuts and bolts
    (±â°èÀÇ)ÀÛµ¿ºÎ(ºÐ);¿îÀü;°æ¿µ;(»ç¹°ÀÇ)±âº» ¿äÁ¡
  • park-and-ride
    Â÷·Î ¿ª±îÁö °¡¼­ ÁÖÂ÷Çϰí ÀüÂ÷³ª ¹ö½º·Î °¥¾ÆÅ¸´Â (¹æ½Ä)
  • quick and dirty
    (Ä«¿îÅͽÄÀÇ)°£ÀÌ ½Ä´ç(snack bar)
  • rag-and-none man
    ³Õ¸¶ÁÖÀÌ
  • rank-and-file
    Æò»ç¿øÀÇ;(ÁöµµÀÚ°¡ ¾Æ´Ñ)ÀÏ¹Ý Á¶ÇÕ¿øÀÇ;¼­¹Î.ÀÏ¹Ý ´ëÁßÀÇ;(Àå±³°¡ ¾Æ´Ñ)»çº´ÀÇ
  • rank-and-filer
    »çº´;ÀϹݽùÎ;¼­¹Î;Æò»ç¿øµé;Æò´ç¿øµé
  • reach and frequency
    µµ´Þµµ¿Í µµ´Þ Ƚ¼ö(ÀÏ·ÃÀÇ ±¤°í Ȱµ¿À¸·Î ±× °­°í°¡ ¾î´À Á¤µµ ħÅõ Çߴ°¡¸¦ ÃøÁ¤ÇÒ ¶§ »ç¿ëµÇ´Â µÎ°¡Áö ¿ä¼Ò)
  • reaper and binder
    ¹ÙÀδõ(º£¾î¼­ ´Ù¹ßÀ» ¹­´Â ±â°è)
  • rest and recuperation
    (º´»çÀÇ)ÈÞ°¡¿Í ÈÞ¾ç
  • rhythm and blues
    ¸®µë ¾Øµå ºí·ç½º(ÈæÀÎ À½¾ÇÀÇ ÀÏÁ¾,rock'n'rollÀÇ ¸ðü)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á